http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-0600706-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad0d08d4f8c973cde02941dbc22ec096 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2006-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_765e7c4902a74de926287f3cc8612c29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6898a908730064c25bd234c709ff824 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a65d98a79870c520798936b902ee79d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d98b2c22da8dbb0e17bd1c5d8630b9a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a5d752e6e743c2aa4f99d3940f60a97 |
| publicationDate | 2009-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-0600706-A2 |
| titleOfInvention | Tricyclic benzo[4,5]thieno-[2,3-d]pyrimidin-4-yl amines, pharmaceutically acceptable salts of them, process for their preparation and pharmaceutical compositions containing the same |
| abstract | SUMMARY OF THE INVENTION The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein: R 1 is hydrogen, phenyl, mono-, di-, tri-, tetra- or pentyl-substituted phenyl, five, or \ t six-membered, substituted or unsubstituted heterocyclic group containing one or more heteroatoms, preferably pyrazole, imidazole, isoxazole, furan, pyrrole, thiophene, thiazole, isothiazole, triazole, pyran, pyridine, pyrimidine, dioxane, morpholine, thiomorpholine, pyridazine, pyrazine, piperazine , R2 is hydrogen, substituted or unsubstituted alkyl or cycloalkyl, A 'is methylene (CH2), methylidene (CH). The invention also relates to a process for the preparation of compounds of formula (I). The present invention relates to the use of the compounds of formula (I) and their pharmaceutically acceptable salts as active ingredients of pharmaceutical compositions. |
| priorityDate | 2006-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 300.